Tag Archives: IOM

Guest Post: CFSAC Testimony of Andrew Bokelman

Andrew Bokelman was scheduled to deliver public comment to the CFS Advisory Committee on June 17th and was the first telephone commenter. His call was terminated by the operator prior to his 3 minutes being up. After protest on Andrew’s … Continue reading

Posted in Advocacy | Tagged , , , , , , , , | 5 Comments

Guest Post: CFSAC Comments of Charmian Proskauer

Charmian delivered these comments at today’s CFS Advisory Committee meeting. She has kindly given me permission to publish them here in their entirety. My name is Charmian Proskauer, and I currently serve as President of the Massachusetts CFIDS/ME & FM … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , | 1 Comment

A Different CFSAC

It’s that time again: meaning it is time for another CFS Advisory Committee meeting. Due to the make up day in March, the meetings have fallen very close together. Presumably this spring meeting puts the calendar back on track (but … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , | Comments Off on A Different CFSAC

Will the Real P2P Please Stand Up?

What is the purpose of the ME/CFS P2P meeting at NIH? You would think that we would know by now, since Assistant Secretary Dr. Howard Koh first announced the effort in October 2012. But to say the rhetoric has evolved … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , , , , | 22 Comments

IOM: Sum of the Whole Matter

The IOM panel on ME/CFS held its second (and likely final) public meeting on May 5, 2014. On display near the meeting room was this painting by Robert Van Vranken: Untitled (Everything at once, or one thing at a time?). … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , | 12 Comments

Protocol for Disaster?

The study protocol for the systematic review of ME/CFS was posted by the Agency for Healthcare and Research Quality yesterday. It’s a recipe for disaster on its own, and within the broader context of the NIH P2P Workshop it’s even … Continue reading

Posted in Advocacy, Commentary, Research | Tagged , , , , , , , , , , , , , , , , , | 44 Comments

Don’t Silence Yourself

On May 5th, the IOM panel creating new diagnostic criteria for ME/CFS will hold its second public meeting. The only way you can provide input is by submitting written comments, unless you are an invited speaker. I’m here to plead … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , | 62 Comments

Reading Tea Leaves

In a report issued on March 12, the IOM panel tasked with creating a new case definition for Gulf War Illness declined to do so. This is the first time the IOM was attempting to create a disease case definition, … Continue reading

Posted in Advocacy | Tagged , , , , , , , , | 4 Comments

Silver Platter of Frustration

Yesterday’s CFS Advisory Committee meeting was insane. Wait, maybe the meeting just drove me insane. Or was the whole thing just insanely inane? I don’t even know anymore. Wait a second, hang on. Ok, let me start again. Yesterday’s CFS … Continue reading

Posted in Advocacy, Commentary | Tagged , , , , , , , , , , , , , , | 14 Comments

Systematic Overreaching

A study published last month* by a group from Norway reports a systematic review of ME/CFS case definitions. It’s important because the Institute of Medicine panel is likely conducting a similar process as part of its work, but the study … Continue reading

Posted in Research | Tagged , , , , , , | 7 Comments